Follow
hu, zheyi
hu, zheyi
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
The role of human carboxylesterases in drug metabolism: have we overlooked their importance?
S Casey Laizure, V Herring, Z Hu, K Witbrodt, RB Parker
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (2 …, 2013
4282013
Dose-dependent association between UGT1A1* 28 genotype and irinotecan-induced neutropenia: low doses also increase risk
ZY Hu, Q Yu, Q Pei, C Guo
Clinical Cancer Research 16 (15), 3832-3842, 2010
1622010
Dose-dependent association between UGT1A1∗ 28 polymorphism and irinotecan-induced diarrhoea: a meta-analysis
ZY Hu, Q Yu, YS Zhao
European journal of cancer 46 (10), 1856-1865, 2010
1212010
Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis
SC Laizure, RB Parker, VL Herring, ZY Hu
Drug Metabolism and Disposition 42 (2), 201-206, 2014
1082014
A phase I/Ib trial of the VEGFR-sparing multikinase RET inhibitor RXDX-105
A Drilon, S Fu, MR Patel, M Fakih, D Wang, AJ Olszanski, D Morgensztern, ...
Cancer discovery 9 (3), 384-395, 2019
1042019
Combinatorial metabolism notably affects human systemic exposure to ginsenosides from orally administered extract of Panax notoginseng roots (Sanqi)
Z Hu, J Yang, C Cheng, Y Huang, F Du, F Wang, W Niu, F Xu, R Jiang, ...
Drug Metabolism and Disposition 41 (7), 1457-1469, 2013
742013
Sex-dependent differences in cytochrome P450 3A activity as assessed by midazolam disposition in humans: a meta-analysis
ZY Hu, YS Zhao
Drug metabolism and disposition 38 (5), 817-823, 2010
542010
Conventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in …
ZY Hu, RB Parker, VL Herring, SC Laizure
Analytical and bioanalytical chemistry 405, 1695-1704, 2013
532013
Effects of alcohol on human carboxylesterase drug metabolism
RB Parker, ZY Hu, B Meibohm, SC Laizure
Clinical pharmacokinetics 54, 627-638, 2015
442015
Physiologically based pharmacokinetic modelling and in vivo [I]/Ki accurately predict P‐glycoprotein‐mediated drug‐drug interactions with dabigatran etexilate
Y Zhao, ZY Hu
British journal of pharmacology 171 (4), 1043-1053, 2014
392014
Oral bioavailability and brain penetration of (−)‐stepholidine, a tetrahydroprotoberberine agonist at dopamine D1 and antagonist at D2 receptors, in rats
Y Sun, J Dai, Z Hu, F Du, W Niu, F Wang, F Liu, G Jin, C Li
British journal of pharmacology 158 (5), 1302-1312, 2009
382009
Simultaneous determination of 6β-hydroxycortisol and cortisol in human urine and plasma by liquid chromatography with ultraviolet absorbance detection for phenotyping the CYP3A …
Z Hu, Q Gong, X Hu, L Wang, Y Cao, W Cao, Q Yu, Z Cheng
Journal of Chromatography B 826 (1-2), 238-243, 2005
382005
CYP3A4-mediated pharmacokinetic interactions in cancer therapy
D Tian, Z Hu
Current Drug Metabolism 15 (8), 808-817, 2014
342014
Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics
H Lou, M Liu, W Qu, Z Hu, E Brunson, J Johnson, H Almoazen
Drug Development and Industrial Pharmacy 40 (7), 910-918, 2014
342014
HPLC–MS–MS for the simultaneous determination of atorvastatin and amlodipine in plasma of hypertensive patients
Q Yu, ZY Hu, FY Zhu, JH Zhu, LL Wan, Y Li, C Guo
Chromatographia 73, 257-262, 2011
342011
Measurement of caffeine and its three primary metabolites in human plasma by HPLC‐ESI‐MS/MS and clinical application
F Chen, ZY Hu, RB Parker, SC Laizure
Biomedical Chromatography 31 (6), e3900, 2017
332017
Association between Common CYP1A2 Polymorphisms and Theophylline Metabolism in Non‐smoking Healthy Volunteers
L Wang, Z Hu, X Deng, Y Wang, Z Zhang, ZN Cheng
Basic & clinical pharmacology & toxicology 112 (4), 257-263, 2013
302013
A physiologically based pharmacokinetic model of alvespimycin in mice and extrapolation to rats and humans
ZY Hu, J Lu, Y Zhao
British journal of pharmacology 171 (11), 2778-2789, 2014
272014
Determination of sinomenine in human plasma by HPLC/ESI/ion trap mass spectrum
YM Yao, ZR Tan, ZY Hu, X Guo, ZN Cheng, LS Wang, HH Zhou
Clinica chimica acta 356 (1-2), 212-217, 2005
272005
Pharmacokinetics of imipenem/cilastatin burn intensive care unit patients undergoing high‐dose continuous venovenous hemofiltration
BA Boucher, JQ Hudson, DM Hill, JM Swanson, GC Wood, SC Laizure, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (12 …, 2016
252016
The system can't perform the operation now. Try again later.
Articles 1–20